CREDIT SUISSE AG/ - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$5,613,000
+742.8%
930,908
+402.8%
0.00%
+300.0%
Q3 2019$666,000
+60.5%
185,146
+19.4%
0.00%
Q2 2019$415,000
-7.8%
155,061
+2.2%
0.00%
Q1 2019$450,000
+13.6%
151,689
-38.9%
0.00%
Q4 2018$396,000
-21.7%
248,279
+80.5%
0.00%
Q3 2018$506,000
-9.5%
137,541
-30.4%
0.00%
-100.0%
Q2 2018$559,000
-17.7%
197,605
+7.9%
0.00%0.0%
Q1 2018$679,000
+38.3%
183,066
+7.1%
0.00%
Q4 2017$491,000
-27.5%
170,897
+13.4%
0.00%
-100.0%
Q3 2017$677,000
+29.7%
150,683
+32.7%
0.00%0.0%
Q2 2017$522,000
-47.9%
113,582
-52.2%
0.00%0.0%
Q1 2017$1,002,000
+110.1%
237,819
+106.0%
0.00%
Q4 2016$477,000
-62.4%
115,458
-26.2%
0.00%
-100.0%
Q3 2016$1,267,000
-20.3%
156,466
-23.3%
0.00%
-50.0%
Q2 2016$1,590,000
+20.2%
203,870
+19.0%
0.00%0.0%
Q1 2016$1,323,000
+107.7%
171,316
+190.4%
0.00%
+100.0%
Q4 2015$637,000
-18.1%
58,985
-47.6%
0.00%0.0%
Q3 2015$778,000
-76.1%
112,577
-69.4%
0.00%
-66.7%
Q2 2015$3,262,000
+133.8%
368,214
+160.2%
0.00%
+200.0%
Q1 2015$1,395,000
-17.7%
141,527
+2.3%
0.00%
-50.0%
Q4 2014$1,695,000
+61.7%
138,402
+31.7%
0.00%
+100.0%
Q3 2014$1,048,000
-24.8%
105,104
-42.9%
0.00%0.0%
Q2 2014$1,393,000
+342.2%
183,984
+92.4%
0.00%
Q1 2014$315,000
-53.6%
95,616
-53.2%
0.00%
-100.0%
Q4 2013$679,000
-5.2%
204,414
-13.9%
0.00%0.0%
Q3 2013$716,000
-64.9%
237,369
-4.8%
0.00%
-50.0%
Q2 2013$2,040,000
+0.1%
249,286
+7.1%
0.00%0.0%
Q1 2013$2,037,000232,7620.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders